{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:52:49Z","timestamp":1783745569914,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.surg.2019.06.043","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:03:26Z","timestamp":1568912606000},"page":"168-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis"],"prefix":"10.1016","volume":"167","author":[{"given":"T.K.","family":"Pandian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie C.","family":"Lubitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay E.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia E.","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2019.06.043_bib1","first-page":"1137","article-title":"A\u00a0comparative study of serum ultrafiltrable, ionized, and total calcium in the diagnosis of primary hyperparathyroidism in patients with intermittent or no elevation in total calcium","volume":"104","author":"Forster","year":"1988","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2019.06.043_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0002-9343(69)90222-8","article-title":"Normocalcemic primary hyperparathyroidism","volume":"47","author":"Wills","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.surg.2019.06.043_bib3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00268-018-4512-2","article-title":"Classic primary hyperparathyroidism versus normocalcemic and normohormonal variants: Do they really differ?","volume":"42","author":"Kiriakopoulos","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib4","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2019.06.043_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2017.1620","article-title":"The definitive management of primary hyperparathyroidism who needs an operation?","volume":"317","author":"Campbell","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2019.06.043_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/archsurg.1992.01420100015003","article-title":"Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery","volume":"127","author":"Siperstein","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.amjsurg.2014.01.005","article-title":"Normocalcemic hyperparathyroidism: Preoperatively a disease, postoperatively cured?","volume":"207","author":"Stuart","year":"2014","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib8","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2013-1300","article-title":"Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations","volume":"98","author":"Cusano","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2019.06.043_bib9","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of\u00a0asymptomatic primary hyperparathyroidism: Summary statement from the\u00a0fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2019.06.043_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MED.0000000000000198","article-title":"An overview of normocalcemic primary hyperparathyroidism","volume":"22","author":"Pawlowska","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.surg.2019.06.043_bib11","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2019.06.043_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1055\/a-0752-4533","article-title":"Normocalcemic primary hyperparathyroidism: A comparison with the hypercalcemic form in a tertiary referral population","volume":"50","author":"Pierreux","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.surg.2019.06.043_bib13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/0194599818793879","article-title":"Surgical management of normocalcemic primary hyperparathyroidism and the impact of intraoperative parathyroid hormone testing on outcome","volume":"159","author":"Trinh","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.surg.2016.08.054","article-title":"Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism","volume":"161","author":"Lim","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2019.06.043_bib15","first-page":"344","article-title":"Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?","volume":"402","author":"Traini","year":"2017","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SLA.0b013e3181859f71","article-title":"Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: Analysis of 1158 cases","volume":"248","author":"Siperstein","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4158\/EP15704.OR","article-title":"Primary hyperparathyroidism, with a focus on management of the normocalcemic form: To treat or not to treat?","volume":"22","author":"\u0160iprov\u00e1","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.surg.2019.06.043_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00268-012-1438-y","article-title":"Surgical management of normocalcemic primary hyperparathyroidism","volume":"36","author":"Wade","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib19","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1245\/s10434-013-3190-4","article-title":"Multigland disease and slower decline in intraoperative PTH characterize mild primary hyperparathyroidism","volume":"20","author":"Schneider","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2019.06.043_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archsurg.141.8.777","article-title":"Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: A simple and accurate scoring model","volume":"141","author":"Kebebew","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2019.06.043_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1245\/s10434-018-6998-0","article-title":"Biochemical and skeletal outcomes of parathyroidectomy for normocalcemic (incipient) primary hyperparathyroidism","volume":"26","author":"Sho","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606019304659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606019304659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:53:52Z","timestamp":1758538432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606019304659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0039606019304659"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2019.06.043","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736656488.793571290","asserted-by":"object"}]},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2019.06.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}